OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C
OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C Kurs - 1 Jahr
Baader Bank gettex Düsseldorf Lang & Schwarz München Stuttgart Tradegate XETRA QuotrixWichtige Stammdaten
Emittent | OSSIAM |
Auflagedatum | 10.11.2017 |
Kategorie | Aktien |
Fondswährung | EUR |
Benchmark | |
Ausschüttungsart | Thesaurierend |
Total Expense Ratio (TER) | 0,17 % |
Fondsgröße | 291.067.658,89 |
Replikationsart | Physisch vollständig |
Morningstar Rating | - |
Anlageziel OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR
So investiert der OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR: The investment objective of the Fund is to replicate, before the Fund's fees and expenses, the performance of the Bloomberg PAB Europe DM ex Eurozone Large & Mid Cap Net Return Index (the “Index”, ticker: EUXPABNL) closing level. The Fund is a financial product that pursuant to Article 9(3) of Regulation (EU) 2019/2088 of the European Parliament and of the Council of 27 November 2019 on sustainability-related disclosures in the financial services sector (the “SFDR”) has the objective of reducing carbon emissions in view of achieving the long-term global warming objectives of the Paris Agreement through the replication of the Index. The Index is a Bloomberg Global Equity Paris-Aligned Index expressed in EUR, calculated and published by Bloomberg (the "Index Provider"). The anticipated level of tracking error in normal conditions is 1.00% over a one-year period.
Der OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR gehört zur Kategorie "Aktien".
Wertentwicklung (NAV) WKN: A2DVG2
3 Monate | 6 Monate | 1 Jahr | 3 Jahre | 5 Jahre | 2025 | |
---|---|---|---|---|---|---|
Performance | -8,11 % | -10,11 % | -2,63 % | +3,56 % | +54,81 % | -7,91 % |
Outperformance ggü. Kategorie | -0,32 % | -1,84 % | +1,57 % | +1,75 % | +8,51 % | +1,91 % |
Max Verlust | - | - | -10,98 % | -22,88 % | -25,57 % | - |
Kurs | - | - | - | - | - | 148,49 € |
Hoch | - | - | 177,04 € | - | - | - |
Tief | - | - | 150,34 € | - | - | - |
Kennzahlen ISIN: LU1655103486
Name | 1 Jahr | 3 Jahre | 5 Jahre | 10 Jahre |
---|---|---|---|---|
Volatilität | 11,40 % | 13,48 % | 12,89 % | |
Sharpe Ratio | +0,39 | +0,30 | +0,85 |
Zusammensetzung WKN: A2DVG2
Größte Positionen ISIN: LU1655103486
Name | ISIN | Marktkapitalisierung | Gewichtung |
---|---|---|---|
Novo Nordisk AS Class B | DK0062498333 | 258.024.447.225 € | 5,79 % |
Nestle SA | CH0038863350 | 235.033.347.031 € | 4,79 % |
AstraZeneca PLC | GB0009895292 | 186.700.694.986 € | 4,66 % |
Novartis AG Registered Shares | CH0012005267 | 180.338.137.117 € | 4,66 % |
Roche Holding AG | CH0012032048 | 213.198.508.363 € | 4,37 % |
HSBC Holdings PLC | GB0005405286 | 151.076.090.994 € | 3,86 % |
Unilever PLC | GB00B10RZP78 | 210.623.761.424 € | 3,12 % |
RELX PLC | GB00B2B0DG97 | 77.669.901.882 € | 2,19 % |
Compagnie Financiere Richemont SA Class A | CH0210483332 | 84.408.997.048 € | 1,99 % |
Zurich Insurance Group AG | CH0011075394 | 84.941.184.391 € | 1,91 % |
Summe Top 10 | 37,33 % |
Weitere ETFs mit gleicher Benchmark
ETF | TER | Größe | Perf 1J |
---|---|---|---|
OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR | 0,17 % | 291,07 Mio. € | -2,63 % |
iShares MSCI USA ESG Enhanced CTB UCITS ETF EUR Hedged Acc | 0,10 % | 17,33 Mrd. € | -4,09 % |
Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C | 0,10 % | 16,63 Mrd. € | +3,44 % |
Amundi Index Solutions - Amundi EURO Corporates UCITS ETF DR EUR C | 0,14 % | 6,25 Mrd. € | +3,89 % |
Amundi S&P 500 Screened UCITS ETF - Acc | 0,15 % | 4,93 Mrd. € | -3,80 % |